Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03581357 · ClinicalTrials.gov registry record · NA
Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors
A NA study, sponsored by University of Hawaii.
- Completed
- Registry status
- NA
- Development phase
- 302
- Enrollment target
NCT03581357: Completed NA study, sponsored by University of Hawaii.
NCT03581357 is a NA study that has completed, run by University of Hawaii. The registered enrollment target is 302 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03581357, a NA study, has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- NA
- Development phase
- 302 participants
- Enrollment target
Study Summary
Evaluate the impact and satisfaction of Mobile Mindfulness Meditation on anxiety, pain, fatigue, trauma, and sleep in cancer survivors.
Primary Outcome
Anxiety will be measured with the GAD-7, which entails respondents indicating how much in the past week they experienced anxiety. Participants are asked to provide their responses on a 5-point Likert type scale, with options ranging from "never" to "always."
Interventions
- BEHAVIORAL Mindfulness Coach
- BEHAVIORAL Mobile Mindfulness Meditation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2019-04-03 |
| Est. Completion | 2023-07-11 |
| Phase | NA |
What the finished NCT03581357 record still lists
NCT03581357 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 2 interventions - of which Mindfulness Coach is the first listed.
NCT03581357 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03581357 about?
NCT03581357 is a clinical study titled "Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors". Evaluate the impact and satisfaction of Mobile Mindfulness Meditation on anxiety, pain, fatigue, trauma, and sleep in cancer survivors.
What is the current status of trial NCT03581357?
This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2019-04-03. Estimated completion is 2023-07-11.
What interventions are being tested in trial NCT03581357?
The interventions under investigation include: Mindfulness Coach (BEHAVIORAL), Mobile Mindfulness Meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03581357?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03581357's enrollment target sits among peer trials
302 330th of 2000 higher than 1,671 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI